Lucia Barlettani

Ms. Lucia Barlettani

University of Pisa, Pisa, Tuscany, Italy
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2022 in Crystals
Verified
Journal Article
Open access
PDF file
Lidia CicconeLidia Ciccone
Lidia Ciccone
Nicolo TonaliNicolo Tonali
Nicolo Tonali
CGCarole Fruchart Gaillard
Carole Fruchart Gaillard
Lucia BarlettaniLucia Barlettani
Lucia Barlettani
ARArmando Rossello
Armando Rossello
Susanna NencettiSusanna Nencetti
Susanna Nencetti
Plants are rich in secondary metabolites, which are often useful as a relevant source of nutraceuticals. Quercetin (QUE) is a flavonol aglycone able to bind Transthyretin (TTR), a plasma protein that under pathological conditions can lose its native structure leading to fibrils formation and amyloid diseases onset. Here, the dual nature of five quercetin 3-O-glycosylated flavonol derivatives, isolated from different plant species, such as possible binders of TTR and antioxidants, was investigated. The crystal structure of 3-O-β-D-galactopyranoside in complex with TTR was solved, suggesting that not only quercetin but also its metabolites can contribute to stabilizing the TTR tetramer.

1 February 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
Lidia CicconeLidia Ciccone
Lidia Ciccone
Susanna NencettiSusanna Nencetti
Susanna Nencetti
ARArmando Rossello
Armando Rossello
Lucia BarlettaniLucia Barlettani
Lucia Barlettani
Nicolo TonaliNicolo Tonali
Nicolo Tonali
EOElisabetta Orlandini
Elisabetta Orlandini
Eicosapentaenoic acid (EPA; 20:5) and docosahexaenoic acid (DHA; 22:6), two omega-3 poly-unsaturated fatty acids (PUFAs), are the main components in oil derived from fish and other marine organisms. EPA and DHA are commercially available as dietary supplements and are considered to be very safe and contribute to guaranteeing human health. Studies report that PUFAs have a role in contrasting neurodegenerative processes related to amyloidogenic proteins, such as β-amyloid for AD, α-synuclein in PD, and transthyretin (TTR) in TTR amyloidosis. In this context, we investigated if EPA and DHA can interact directly with TTR, binding inside the thyroxin-binding pockets (T4BP) that contribute to the tetramer stabilization. The data obtained showed that EPA and DHA can contribute to stabilizing the TTR tetramer through interactions with T4BP.

22 September 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Lidia CicconeLidia Ciccone
Lidia Ciccone
CCCaterina Camodeca
Caterina Camodeca
Nicolo TonaliNicolo Tonali
Nicolo Tonali
Lucia BarlettaniLucia Barlettani
Lucia Barlettani
ARArmando Rossello
Armando Rossello
EOElisabetta Orlandini
Elisabetta Orlandini
A series of new hybrid derivatives 1a–c, 2a–c, 3a–c, 4a–c, 5a–c, inspired by nature, were synthesized and studied as multifunctional agents for the treatment of Alzheimer’s disease (AD). These compounds were designed to merge together the trifluoromethyl benzyloxyaminic bioactive moiety, previously identified, with different acids available in nature. The ability of the synthesized compounds to chelate biometals, such as Cu2+, Zn2+ and Fe2+, was studied by UV–Vis spectrometer, and through a preliminary screening their antioxidant activity was evaluated by DPPH. Then, selected compounds were tested by in vitro ABTS free radical method and ex vivo rat brain TBARS assay. Compounds 2a–c, combining the strongest antioxidant and biometal chelators activities, were studied for their ability to contrast Aβ1-40 fibrillization process. Finally, starting from the promising profile obtained for compound 2a, we evaluated if it could be able to induce a positive cross-interaction between transthyretin (TTR) and Aβ in presence and in absence of Cu2+.